Subcutaneous Immunoglobulin Replacement Therapy with Hizentra (R) is Safe and Effective in Children Less Than 5 Years of Age
- Resource Type
- Journal
- Source
JOURNAL OF CLINICAL IMMUNOLOGY ; APR 2014, 34 3, p382-p382, 1p.- Subject
- Language
- English
- ISSN
- 15732592